abstract |
The present invention provides new anti-.alpha.5.beta.1 integrin antibodies, compositions and kits comprising the antibodies, and methods of making and using the antibodies. In particular, production of humanized versions of a hamster .alpha.5.beta.1 integrin monoclonal antibody are disclosed. |